Patent US5972178A successfully refreshed from Google Patents.
Patent US4192885A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4192885A Expired / Lapsed US ⏱️ 0.0 years remaining

Analgesic N-{2-[N'-(2-furylmethyl and 2-thienyl-methyl)-N'-alkylamino]cycloaliphatic}cyanobenzamides

Assignee: Pharmacia and Upjohn Co
•
Filing: 1979-03-08
•
Granted: 1980-03-11
•
Expires: 1999-03-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Cis- and trans-N-(2-aminocycloaliphatic)benzamide compounds of the formula ##STR1## e.g., N-methyl-N-[2-(N-pyrrolidinyl)cyclohexyl]-3,4-dichlorobenzamide, and their pharmaceutically acceptable salts, have been found to have potent analgesic activity, and compositions containing these compounds useful in pharmaceutical dosage unit form for alleviating pain in warm blooded animals, as well as methods for alleviating pain in animals with these compositions. Processes for preparing the compounds are also disclosed.

Inventors

  • 👤 Jacob Szmuszkovicz

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 03:59
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/04; C07D295/12; C07D295/135

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 107 words
A compound of the formula ##STR63## wherein the wavy line (˜) at the 1-position of the cycloaliphatic ring denotes trans-stereoconfiguration of the 1-position substituent with respect to the substituent in position 2 of the same cycloaliphatic ring; n is 1 to 8; R is hydrogen or C 1 to C 3 -alkyl; R 1 is C 1 to C 3 -alkyl; R 2 is a group of the formula ##STR64## wherein T is --O-- or --S--; Q is the radical ##STR65## wherein one of X, Y and Z is cyano and the remaining members of X, Y and Z are hydrogen, and the pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim 107 words
A compound of the formula ##STR63## wherein the wavy line (˜) at the 1-position of the cycloaliphatic ring denotes trans-stereoconfiguration of the 1-position substituent with respect to the substituent in position 2 of the same cycloaliphatic ring; n is 1 to 8; R is hydrogen or C 1 to C 3 -alkyl; R 1 is C 1 to C 3 -alkyl; R 2 is a group of the formula ##STR64## wherein T is --O-- or --S--; Q is the radical ##STR65## wherein one of X, Y and Z is cyano and the remaining members of X, Y and Z are hydrogen, and the pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 17 words
A compound according to claim 1 wherein the compound is trans-4-cyano-N-{2-[N'-(2-furylmethyl)-N'-methylamino]cyclohexyl}-N-methylbenzamide, or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 17 words
A compound according to claim 1 wherein the compound is trans-4-cyano-N-{2[N'-(2-thienylmethyl)-N'-methylamino]cyclohexyl}-N-methylbenzamide or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 44 words
A composition useful in pharmaceutical dosage unit form in an amount ranging from about 0.5 to about 350 mg. per dosage unit for alleviating pain in a warm blooded animals which comprises a compound of claim 1 in combination with a pharmaceutically acceptable carrier.
Claim 6
Dependent Claim 33 words
A method for alleviating pain in a warm blooded animal which comprises administering to the warm blooded animal suffering pain a compound of claim 1 in an amount effective to relieve the pain.
Claim 7
Dependent Claim 29 words
A method according to claim 5 wherein the compound of claim 1 is administered in an amount between about 0.5 and 350 mg. per dose in a pharmaceutical carrier.

References Cited (Backward Citations)

US3510492A Cited
US3647804A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-03-11 1983-09-10 1984-03-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-03-11 1987-09-10 1988-03-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-03-11 1991-09-10 1992-03-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag